Nephros (NEPH) Net Cash Flow Growth (3y) (2013 - 2026)
Nephros (NEPH) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -63.96% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -55.30% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 126.35% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -159.29% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 78.59% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 36.49% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 45.74% |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | -106.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106.78% |
| Dec 31, 2025 | 37.53% |
| Sep 30, 2025 | 34.00% |
| Jun 30, 2025 | 40.94% |
| Mar 31, 2025 | 30.20% |
| Dec 31, 2024 | 76.55% |
| Sep 30, 2024 | 12.38% |
| Jun 30, 2024 | -85.78% |
| Mar 31, 2024 | -102.64% |
| Dec 31, 2023 | -27.60% |
| Sep 30, 2023 | 31.93% |
| Jun 30, 2023 | 28.71% |
| Mar 31, 2023 | -65.21% |
| Dec 31, 2022 | -44.07% |
| Sep 30, 2022 | 19.43% |
| Jun 30, 2022 | -55.39% |
| Mar 31, 2022 | -16.87% |
| Dec 31, 2021 | -51.66% |
| Sep 30, 2021 | -35.79% |
| Jun 30, 2021 | -59.16% |